Skip to main content
Top
Published in: Gut Pathogens 1/2024

Open Access 01-12-2024 | Colorectal Cancer | Correction

Correction to: 16 S rRNA sequencing analysis of the oral and fecal microbiota in colorectal cancer positives versus colorectal cancer negatives in Iranian population

Authors: Sama Rezasoltani, Mehdi Azizmohammad Looha, Hamid Asadzadeh Aghdaei, Seyedesomayeh Jasemi, Leonardo Antonio Sechi, Maria Gazouli, Amir Sadeghi, Shirin Torkashvand, Reyhaneh Baniali, Hartmut Schlüter, Mohammad Reza Zali, Mohammad Mehdi Feizabadi

Published in: Gut Pathogens | Issue 1/2024

Login to get access

Excerpt

Correction to: Rezasoltani et al. Gut Pathogens 2024 Feb 20;16(1):9
Metadata
Title
Correction to: 16 S rRNA sequencing analysis of the oral and fecal microbiota in colorectal cancer positives versus colorectal cancer negatives in Iranian population
Authors
Sama Rezasoltani
Mehdi Azizmohammad Looha
Hamid Asadzadeh Aghdaei
Seyedesomayeh Jasemi
Leonardo Antonio Sechi
Maria Gazouli
Amir Sadeghi
Shirin Torkashvand
Reyhaneh Baniali
Hartmut Schlüter
Mohammad Reza Zali
Mohammad Mehdi Feizabadi
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Gut Pathogens / Issue 1/2024
Electronic ISSN: 1757-4749
DOI
https://doi.org/10.1186/s13099-024-00607-x

Other articles of this Issue 1/2024

Gut Pathogens 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine